Anti asialoglycoprotein receptor antibodies and soluble interleukin-2 receptor levels as marker for inflammation in autoimmune hepatitis

D. Dejica, U. Treichel, A. Pár, O. Chira, K. H. Meyer Zum Büschenfelde

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Circulating anti asialoglycoprotein receptor antibodies (anti-ASGPR) and soluble interleukin-2 receptor levels (sIL-2R) were blindly determined in sera of 23 patients with autoimmune hepatitis and compared to 18 healthy individuals. All patients underwent liver biopsy which was blindly staged and graded. 14 of 23 (61%) patients but none of normal controls showed anti-ASGPR positivity. Eleven of twelve (92%) patients with biopsy-proven grade 3 hepatitis were high-titered anti-ASGPR positive compared to three of eleven patients with grade 1 hepatitis. Mean levels of sIL-2R ± standard deviation were 1,175 ± 663 units/ml in the total number of patients with autoimmune hepatitis comparing to 372 ± 69 units/ml in healthy controls (p <0.001). Eleven of twelve patients with grade 3 hepatitis had significant higher sIL-2R levels (1.669 ± 559) than patients with mild disease (635 ± 113). Chi-square analysis demonstrated a significant correlation between positive anti-ASGPR titer and elevated sIL-2R values. A follow-up analysis of six patients showed a significant decrease of both anti-ASGPR titer and sIL-2R levels after three to nine months of immunosuppressive therapy. These findings suggest that elevated sIL-2R levels and anti-ASGPR titer are associated in patients with autoimmune hepatitis, and - as a function of either T or B cell activation, respectively - could serve as reliable humoral marker for disease-specific activity.

Original languageEnglish
Pages (from-to)15-21
Number of pages7
JournalZeitschrift fur Gastroenterologie
Volume35
Issue number1
Publication statusPublished - 1997

Fingerprint

Asialoglycoprotein Receptor
Autoimmune Hepatitis
Interleukin-2 Receptors
Inflammation
Antibodies
Hepatitis
Biopsy
Immunosuppressive Agents
B-Lymphocytes

Keywords

  • asialoglycoprotein receptor
  • autoantibodies
  • autoimmune hepatitis
  • immunosuppression
  • soluble interleukin-2 receptor

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Anti asialoglycoprotein receptor antibodies and soluble interleukin-2 receptor levels as marker for inflammation in autoimmune hepatitis. / Dejica, D.; Treichel, U.; Pár, A.; Chira, O.; Meyer Zum Büschenfelde, K. H.

In: Zeitschrift fur Gastroenterologie, Vol. 35, No. 1, 1997, p. 15-21.

Research output: Contribution to journalArticle

@article{7f7544f7addc4eb6a255cfd76196d76a,
title = "Anti asialoglycoprotein receptor antibodies and soluble interleukin-2 receptor levels as marker for inflammation in autoimmune hepatitis",
abstract = "Circulating anti asialoglycoprotein receptor antibodies (anti-ASGPR) and soluble interleukin-2 receptor levels (sIL-2R) were blindly determined in sera of 23 patients with autoimmune hepatitis and compared to 18 healthy individuals. All patients underwent liver biopsy which was blindly staged and graded. 14 of 23 (61{\%}) patients but none of normal controls showed anti-ASGPR positivity. Eleven of twelve (92{\%}) patients with biopsy-proven grade 3 hepatitis were high-titered anti-ASGPR positive compared to three of eleven patients with grade 1 hepatitis. Mean levels of sIL-2R ± standard deviation were 1,175 ± 663 units/ml in the total number of patients with autoimmune hepatitis comparing to 372 ± 69 units/ml in healthy controls (p <0.001). Eleven of twelve patients with grade 3 hepatitis had significant higher sIL-2R levels (1.669 ± 559) than patients with mild disease (635 ± 113). Chi-square analysis demonstrated a significant correlation between positive anti-ASGPR titer and elevated sIL-2R values. A follow-up analysis of six patients showed a significant decrease of both anti-ASGPR titer and sIL-2R levels after three to nine months of immunosuppressive therapy. These findings suggest that elevated sIL-2R levels and anti-ASGPR titer are associated in patients with autoimmune hepatitis, and - as a function of either T or B cell activation, respectively - could serve as reliable humoral marker for disease-specific activity.",
keywords = "asialoglycoprotein receptor, autoantibodies, autoimmune hepatitis, immunosuppression, soluble interleukin-2 receptor",
author = "D. Dejica and U. Treichel and A. P{\'a}r and O. Chira and {Meyer Zum B{\"u}schenfelde}, {K. H.}",
year = "1997",
language = "English",
volume = "35",
pages = "15--21",
journal = "Zeitschrift fur Gastroenterologie",
issn = "0044-2771",
publisher = "Karl Demeter Verlag GmbH",
number = "1",

}

TY - JOUR

T1 - Anti asialoglycoprotein receptor antibodies and soluble interleukin-2 receptor levels as marker for inflammation in autoimmune hepatitis

AU - Dejica, D.

AU - Treichel, U.

AU - Pár, A.

AU - Chira, O.

AU - Meyer Zum Büschenfelde, K. H.

PY - 1997

Y1 - 1997

N2 - Circulating anti asialoglycoprotein receptor antibodies (anti-ASGPR) and soluble interleukin-2 receptor levels (sIL-2R) were blindly determined in sera of 23 patients with autoimmune hepatitis and compared to 18 healthy individuals. All patients underwent liver biopsy which was blindly staged and graded. 14 of 23 (61%) patients but none of normal controls showed anti-ASGPR positivity. Eleven of twelve (92%) patients with biopsy-proven grade 3 hepatitis were high-titered anti-ASGPR positive compared to three of eleven patients with grade 1 hepatitis. Mean levels of sIL-2R ± standard deviation were 1,175 ± 663 units/ml in the total number of patients with autoimmune hepatitis comparing to 372 ± 69 units/ml in healthy controls (p <0.001). Eleven of twelve patients with grade 3 hepatitis had significant higher sIL-2R levels (1.669 ± 559) than patients with mild disease (635 ± 113). Chi-square analysis demonstrated a significant correlation between positive anti-ASGPR titer and elevated sIL-2R values. A follow-up analysis of six patients showed a significant decrease of both anti-ASGPR titer and sIL-2R levels after three to nine months of immunosuppressive therapy. These findings suggest that elevated sIL-2R levels and anti-ASGPR titer are associated in patients with autoimmune hepatitis, and - as a function of either T or B cell activation, respectively - could serve as reliable humoral marker for disease-specific activity.

AB - Circulating anti asialoglycoprotein receptor antibodies (anti-ASGPR) and soluble interleukin-2 receptor levels (sIL-2R) were blindly determined in sera of 23 patients with autoimmune hepatitis and compared to 18 healthy individuals. All patients underwent liver biopsy which was blindly staged and graded. 14 of 23 (61%) patients but none of normal controls showed anti-ASGPR positivity. Eleven of twelve (92%) patients with biopsy-proven grade 3 hepatitis were high-titered anti-ASGPR positive compared to three of eleven patients with grade 1 hepatitis. Mean levels of sIL-2R ± standard deviation were 1,175 ± 663 units/ml in the total number of patients with autoimmune hepatitis comparing to 372 ± 69 units/ml in healthy controls (p <0.001). Eleven of twelve patients with grade 3 hepatitis had significant higher sIL-2R levels (1.669 ± 559) than patients with mild disease (635 ± 113). Chi-square analysis demonstrated a significant correlation between positive anti-ASGPR titer and elevated sIL-2R values. A follow-up analysis of six patients showed a significant decrease of both anti-ASGPR titer and sIL-2R levels after three to nine months of immunosuppressive therapy. These findings suggest that elevated sIL-2R levels and anti-ASGPR titer are associated in patients with autoimmune hepatitis, and - as a function of either T or B cell activation, respectively - could serve as reliable humoral marker for disease-specific activity.

KW - asialoglycoprotein receptor

KW - autoantibodies

KW - autoimmune hepatitis

KW - immunosuppression

KW - soluble interleukin-2 receptor

UR - http://www.scopus.com/inward/record.url?scp=0031042353&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031042353&partnerID=8YFLogxK

M3 - Article

C2 - 9123953

AN - SCOPUS:0031042353

VL - 35

SP - 15

EP - 21

JO - Zeitschrift fur Gastroenterologie

JF - Zeitschrift fur Gastroenterologie

SN - 0044-2771

IS - 1

ER -